Unmet Medical Need: Arrhythmia symptoms range from shortness of breath and fatigue, to sudden cardiac arrest or stroke. The disease also greatly decreases quality of life by limiting physical activity and inducing a significant psychological burden. Catheter ablation is a minimally-invasive procedure that is one of the most effective treatments for arrhythmia. Unfortunately, nearly half of patients who undergo a first multi-hour ablation therapy will find that the procedure did not successfully treat their arrhythmia, will often times lead to new arrhythmias, and will most likely need to be repeated at least once.

Envisioned Healthcare Product:  VISIBLATE is a software-based imaging technology that monitors and maps lesion formation in real time during catheter ablation surgery, thus reducing the likelihood of subsequent ablation procedures and reducing costs to the health care system overall.

Stage of Development:  Clinical Trials

September 2016 UPDATE

Collaborative Research Team: Elisa Konofagou, PhD and Elaine Wan, MD

Funding Cycle: 2017-2018